Effects of genetic vs. environmental factors on cardiovascular autonomic function: A twin study

Diabetic Medicine

Volumn 28, Issue 10, 2011, Pages 1241-1248

  Osztovits, J ^a   Horvath T ^b   Littvay, L ^c   Steinbach, R ^b   Jermendy, A ^b   Tarnoki A ^b   Tarnoki D ^b   Metneki J ^d   Kollai, M ^b   Jermendy, G ^a  

^a BAJCSY ZSILINSZKY HOSPITAL   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c CENTRAL EUROPEAN UNIVERSITY   (Hungary)

^d Orszagos Szakfelugyeleti Modszertani Kozpont Hungary   (Hungary)

Author keywords

Baroreflex sensitivity; Cardiovascular autonomic function; Cardiovascular autonomic neuropathy; Heart rate variability; Twin study

Indexed keywords

ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CARDIOVASCULAR AUTONOMIC FUNCTION; CARDIOVASCULAR FUNCTION; CLINICAL ASSESSMENT; CORRELATION ANALYSIS; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; HEART RATE VARIABILITY; HEREDITY; HUMAN; MALE; MONOZYGOTIC TWINS; NORMAL HUMAN; PRESSORECEPTOR REFLEX; RISK ASSESSMENT; TWINS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; FASTING; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TWINS, DIZYGOTIC; TWINS, MONOZYGOTIC; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 80053014049     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03363.x     Document Type: Article

References (29)

1. Pop-Busui R. Cardiac autonomic neuropathy in diabetes. A clinical perspective. Diabetes Care 2010; 33: 434-441.
2. Jermendy G. Clinical consequences of cardiovascular autonomic neuropathy in diabetic patients. Acta Diabetologia 2003; 40: S370-S374.
3. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007; 115: 387-397.
4. La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478-484.
5. Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care 2003; 26: 1895-1901.
6. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
7. Ziegler D, Schatz H, Conrad F, Gries FA, Ulrich H, Reichel G. Effects of treatment with the antioxidant alpha-lipoic acid on cardiac autonomic neuropathy in NIDDM patients. A 4-month randomized controlled multicenter trial (DEKAN Study). Deutsche Kardiale Autonome Neuropathie. Diabetes Care 1997; 20: 369-373.
8. Heath AC, Nyholt DR, Neuman R, Madden PA, Bucholz KK, Todd RD et al. Zygosity diagnosis in the absence of genotypic data: an approach using latent class analysis. Twin Res 2003; 6: 22-26.
9. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996; 17: 354-381.
10. Badra LJ, Cooke WH, Hoag JB, Crossman AA, Kuusela TA, Tahvanainen KU et al. Respiratory modulation of human autonomic rhythms. Am J Physiol Heart Circ Physiol 2001; 280: H2674-H2688.
11. Asparouhov T. Sampling weights in latent variable modeling. Struct Equ Modeling 2005; 12: 411-434.
12. Agresti A. Categorical Data Analysis. Hoboken, NJ: John Wiley and Sons, 2002.
13. Neale MC, Cardon LR. Methodology for Genetic Studies of Twins and Families. Dordrecht-Boston-London: Kluwer Academic Publishers, 1992.
14. Bollen KA, Stein RA. Bootstrapping goodness-of-fit measures in structural equation models. Sociol Methods Res 1992; 21: 205-229.
15. Muthén LK, Muthén BO. Mplus. Statistical Analysis with Latent Variables. User's Guide (1998-2010). Los Angeles: Muthén & Muthén, 2010.
16. Tank J, Jordan J, Diedrich A, Stoffels M, Franke G, Faulhaber HD et al. Genetic influences on baroreflex function in normal twins. Hypertension 2001; 37: 907-910.
17. Lykken DT, Tellegen A, DeRubeis R. Volunteer bias in twin research: the rule of two-thirds. Soc Biol 1978; 25: 1-9.
18. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10years experience in diabetes. Diabetes Care 1985; 8: 491-498.
19. Ziegler D, Laude D, Akila F, Elghozi JL. Time- and frequency-domain estimation of early diabetic cardiovascular autonomic neuropathy. Clin Auton Res 2001; 11: 369-376.
20. Valensi P, Huard JP, Giroux C, Attali JR. Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications 1997; 11: 180-187.
21. Valensi P, Pariès J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications-the French multicenter study. Metabolism 2003; 52: 815-820.
22. Singh JP, Larson MG, O'Donnell CJ, Tsuji H, Evans JC, Levy D. Heritability of heart rate variability: the Framingham Heart Study. Circulation 1999; 99: 2251-2254.
23. Sinnreich R, Friedlander Y, Luria MH, Sapoznikov D, Kark JD. Inheritance of heart rate variability: the kibbutzim family study. Hum Genet 1999; 105: 654-661. Erratum: Hum Genet 2000; 107: 96.
24. Kupper NH, Willemsen G, van den Berg M, de Boer D, Posthuma D, Boomsma DI et al. Heritability of ambulatory heart rate variability. Circulation 2004; 110: 2792-2796.
25. Neumann SA, Lawrence EC, Jennings JR, Ferrell RE, Manuck SB. Heart rate variability is associated with polymorphic variation in the choline transporter gene. Psychosom Med 2005; 67: 168-171.
26. Müller-Nordhorn J, Binting S, Roll S, Willich SN. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J 2008; 29: 1316-1326.
27. Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation 2009; 119: 2886-2893.
28. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type2 diabetes. N Engl J Med 2003; 348: 383-393.
29. Pinna GD, Maestri R, Torunski A, Danilowicz-Szymanowicz L, Szwoch M, La Rovere MT et al. Heart rate variability measures: a fresh look at reliability. Clin Sci (Lond) 2007; 113: 131-140.